Deficiency of FVIII is referred to as hemophilia A, while FIX deficiency is called hemophilia B. Bleeding can be prevented by frequent intravenous injections of recombinant or plasma-derived factor product (2–3 times per week). The gene discussed is F8; the disease is hemophilia B.